首页> 外文期刊>Regulatory peptides. >Adrenomedullin-a regulator of bone formation.
【24h】

Adrenomedullin-a regulator of bone formation.

机译:肾上腺髓质素-骨形成的调节剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Bone growth and maintenance are highly regulated processes. Throughout life, bone constantly undergoes remodelling, maintaining a balance between bone formation by osteoblasts and bone resorption by osteoclasts. This balance depends on the coordinated activities of many systemic hormones and locally acting factors in the bone microenvironment. Understanding the mechanisms of action of these factors provides a better appreciation of the cellular and molecular basis of bone remodelling.Adrenomedullin has recently been found to stimulate the proliferation of osteoblasts in vitro, and to increase indices of bone formation when administered either locally or systemically in vivo. Adrenomedullin receptors, as well as adrenomedullin itself, are expressed in primary osteoblasts and in osteoblast-like cell lines. In this paper we discuss the anabolic effect of adrenomedullin in bone, and present new evidence for a possible role of adrenomedullin in the regulation of cartilage cells. We show that adrenomedullin stimulates proliferation of primary chondrocytes in culture and that mRNA for adrenomedullin and for adrenomedullin receptors are expressed in these cells.Studies of structure-activity relationships have demonstrated that osteotropic effects of adrenomedullin can be retained in peptide fragments of the molecule which lack the parent molecule's vasodilatory properties. Thus, these small peptides, or their analogues, are attractive candidates as anabolic therapies for osteoporosis.
机译:骨骼生长和维持是受到严格监管的过程。在整个生命中,骨骼不断进行重塑,从而在成骨细胞形成的骨与破骨细胞吸收的骨之间保持平衡。这种平衡取决于骨骼微环境中许多全身激素和局部作用因子的协调活动。了解这些因素的作用机理可更好地了解骨骼重塑的细胞和分子基础。最近发现肾上腺髓质素可在体外刺激成骨细胞的增殖,并在局部或全身给药时增加成骨指数。体内。肾上腺髓质素受体以及肾上腺髓质素本身在原代成骨细胞和成骨细胞样细胞系中表达。在本文中,我们讨论了肾上腺髓质素在骨骼中的合成代谢作用,并为肾上腺髓质素在软骨细胞调节中的可能作用提供了新证据。我们显示肾上腺髓质素刺激培养的原代软骨细胞增殖,并且在这些细胞中表达了肾上腺髓质素和肾上腺髓质素受体的mRNA。结构-活性关系的研究表明,肾上腺髓质素的亲骨作用可以保留在缺乏该分子的肽片段中母体分子的血管舒张特性。因此,这些小肽或其类似物作为骨质疏松症的合成代谢疗法是有吸引力的候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号